Adamant Biomedical Investments AG 13F 持仓 · 最近申报 2014年Q4
Adamant Biomedical Investments 在 2014年Q4（报告期截至 2014-12-31）的 SEC 13F 申报中报告了 100 只证券，申报市值合计 4.18 亿美元。前几大持仓：CELG（4.98%）、BIIB（4.32%）、GILD（4.06%）。本季前 25 大持仓中：新建仓 1 只、增持 5 只、减持 13 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | CELG | CELGENE CORPORATION | $20.8M | 4.98% | 186,170 | 减持 |
| 2 | BIIB | BIOGEN IDEC INC | $18.1M | 4.32% | 53,250 | 减持 |
| 3 | GILD | GILEAD SCIENCES INC | $17.0M | 4.06% | 180,390 | 减持 |
| 4 | AMGN | AMGEN INC | $15.1M | 3.62% | 95,000 | 减持 |
| 5 | AGN | ACTAVIS PLC | $13.3M | 3.17% | 51,590 | 减持 |
| 6 | UNH | UNITEDHEALTH GROUP INCORPORATED | $11.6M | 2.78% | 115,000 | 减持 |
| 7 | VTRS | MYLAN INC | $11.3M | 2.69% | 200,000 | 减持 |
| 8 | CTRX | CATAMARAN CORPORATION | $10.7M | 2.57% | 206,820 | 增持 |
| 9 | ALXN | ALEXION PHARMACEUTICALS INC | $10.5M | 2.52% | 57,000 | 减持 |
| 10 | MDT | MEDTRONIC INC | $8.8M | 2.10% | 121,500 | 减持 |
| 11 | VRTX | VERTEX PHARMACEUTICALS INC | $8.7M | 2.07% | 73,000 | 持平 |
| 12 | REGN | REGENERON PHARMACEUTICALS INC | $8.6M | 2.06% | 21,000 | 增持 |
| 13 | MCK | MCKESSON CORPORATION | $8.5M | 2.03% | 41,000 | 持平 |
| 14 | EARS | AURIS MEDICAL HOLDING AG | $8.5M | 2.02% | 2.2M | 持平 |
| 15 | MNKKQ | MALLINCKRODT PUBLIC LIMITED COMPANY | $7.9M | 1.89% | 80,000 | 持平 |
| 16 | ABT | ABBOTT LABORATORIES | $7.8M | 1.86% | 173,000 | 减持 |
| 17 | AGN1 | ALLERGAN INC | $7.4M | 1.78% | 35,000 | 持平 |
| 18 | ILMN | ILLUMINA INC | $7.4M | 1.76% | 40,000 | 减持 |
| 19 | ACAD | ACADIA PHARMACEUTICALS INC | $6.5M | 1.56% | 205,000 | 增持 |
| 20 | MDVN | MEDIVATION INC | $6.5M | 1.55% | 65,000 | 增持 |
| 21 | CAH | CARDINAL HEALTH INC | $6.5M | 1.54% | 80,000 | 减持 |
| 22 | IONS | ISIS PHARMACEUTICALS INC | $6.2M | 1.48% | 100,000 | 减持 |
| 23 | AKRXQ | AKORN INC | $5.8M | 1.38% | 160,000 | 增持 |
| 24 | HSP | HOSPIRA INC | $5.5M | 1.32% | 90,000 | 新建仓 |
| 25 | LLY | ELI LILLY AND COMPANY | $5.5M | 1.32% | 80,000 | 持平 |
来源：SEC 13F 申报文件 · 截至 2014-12-31
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR